Searched for
NICOTINE REPLACEMENT BRANDS
Dr Reddy's Laboratories Q2 Results: Profit rises 7% YoY to Rs 1,347 crore, revenue up 10%Dr Reddy's Laboratories Q2 Results: Generic drugmaker Dr Reddy's Labs reported 7% growth in its net profit at Rs 1,347 crore in the Septemb...- Dr Reddy’s shares slip nearly 2% on investor concerns amid $50 million foray into anti-vertigo categoryDr. Reddy's Laboratories' shares experienced a slight dip following the announcement of their acquisition of Stugeron from Johnson & Johnso...
- Dr. Reddy's Laboratories shares jump 2% as Q1 net profit jumps 2% YoY. Should you invest?Dr. Reddy's Laboratories shares: The company reported operational revenue of ₹8,545 crore, reflecting a solid 11% year-on-year increase. Ho...
- Dr. Reddy's Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%Dr Reddy's Laboratories Q1 Results: Pharma major Dr. Reddy's Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolida...
- Dr. Reddy's eyes aspirational goal to be in top five in the Indian marketDr. Reddy's Laboratories is prioritizing innovative product launches through strategic partnerships to achieve a 15-16% growth in the India...
- Dr Reddy's Labs, Mankind Pharma riding on strong growth driversIndian pharmaceutical giants, Dr. Reddy's Labs and Mankind Pharma, reported impressive double-digit revenue growth in the September quarter...
- Dr Reddy's completes acquisition of Haleon's NRT portfolioDr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP 458 million. T...
- Dr Reddy's to buy nicotine replacement brands from UK-based Haleon for $632 millionThe portfolio to be acquired consists of Nicotinell, a global leader in the NRT category with an extensive footprint in over 30 countries s...
- Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notifiedFor the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also ...
- Diabetes, patented TB, HIV drugs enter essential listPopular anti-diabetes drug teneligliptin, insulin glargine injection, Common antibiotics like meropenem, Cefuroxime have been included in t...
- Several antibiotics, other drugs may get cheaperMedicines and devices listed in the NLEM must be sold at the prices set by National Pharmaceuticals Pricing Authority (NPPA), while those i...
- Throes of nicotine withdrawal: Understanding the science of addictionThe science of nicotine addiction has come a long way since 1964.
- Why quitting smoking is crucial during COVID-19 pandemicSmoking substantially worsens health outcomes for COVID-19 patients.
- Smokers are more vulnerable to Covid-19Using Nicotine Replacement Therapy can double your chances of quitting smoking (9)
- Nicotex joins hands with Karnataka, Goa governments to encourage smoking cessation with NRTTo promote safe behaviour, Nicotex has collaborated with the efforts of Karnataka to protect the frontline workers, who are presently engag...
- Ban on e-cigarettes may actually benefit ITCE-cigarettes and other vaping devices are supposed to help smokers quit smoking in search of healthier alternatives.
- Dr Reddy's acquires Habitrol brandDr Reddy's Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc.
- ITC forays into E-cigarettes segment, will be rolled out pan-India in phasesITC group has forayed into electronic cigarettes to offset shrinking sales of its conventional tobacco cigarettes due to recurrent price in...
- Combo treatments boost smokers' ability to quitTo measure the benefit of combining treatments, the researchers enrolled 349 adults who reported smoking 10 or more cigarettes a day.
- As smoking gets dearer, ITC bets on nicotine gumThe big daddy of cigarette business, ITC, is now gearing up to woo smokers with an antidote -- Kwiknic nicotine chewing gums -- to their “i...
Load More
